-
EP2341931
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2341931
| EP2341931 - VACCINE COMPOSITION FOR USE AGAINST INFLUENZA [Right-click to bookmark this link] | Status | The application has been refused Status updated on 14.10.2016 Database last updated on 22.08.2024 | Most recent event Tooltip | 14.10.2016 | Refusal of application | published on 16.11.2016 [2016/46] | Applicant(s) | For all designated states ABIVAX 5 rue de la Baume 75008 Paris / FR | For all designated states Serra, Vincent 8 place de l'Eglise 91070 Bondoufle / FR | [2014/51] |
| Former [2011/28] | For all designated states Wittycell 8b rue Gabriel Voisin 51100 Reims / FR | ||
| For all designated states Serra, Vincent 8 place de l'Eglise 91070 Bondoufle / FR | Inventor(s) | 01 /
SERRA, Vincent 8 place de l'Eglise F-91070 Bondoufle / FR | [2011/28] | Representative(s) | Lavoix 2, place d'Estienne d'Orves 75441 Paris Cedex 09 / FR | [N/P] |
| Former [2011/28] | Blot, Philippe Robert Emile Cabinet Lavoix 2, place d'Estienne d'Orves 75441 Paris Cedex 09 / FR | Application number, filing date | 09783735.5 | 05.10.2009 | [2011/28] | WO2009EP62894 | Priority number, date | US20080103669P | 08.10.2008 Original published format: US 103669 P | [2011/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010040710 | Date: | 15.04.2010 | Language: | EN | [2010/15] | Type: | A1 Application with search report | No.: | EP2341931 | Date: | 13.07.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.04.2010 takes the place of the publication of the European patent application. | [2011/28] | Search report(s) | International search report - published on: | EP | 15.04.2010 | Classification | IPC: | A61K39/145 | [2011/28] | CPC: |
A61K39/145 (EP,US);
A61K39/12 (EP,US);
A61K39/39 (EP,US);
A61P31/16 (EP);
A61P37/04 (EP);
A61K2039/55511 (EP,US);
A61K2039/55555 (EP,US);
A61K2039/58 (EP,US);
A61K2039/70 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/28] | Title | German: | IMPFSTOFFZUSAMMENSETZUNG ZUR VERWENDUNG GEGEN INFLUENZA | [2011/28] | English: | VACCINE COMPOSITION FOR USE AGAINST INFLUENZA | [2011/28] | French: | COMPOSITION VACCINALE UTILISABLE CONTRE LA GRIPPE | [2011/28] | Entry into regional phase | 07.04.2011 | National basic fee paid | 07.04.2011 | Designation fee(s) paid | 07.04.2011 | Examination fee paid | Examination procedure | 07.04.2011 | Amendment by applicant (claims and/or description) | 07.04.2011 | Examination requested [2011/28] | 03.04.2014 | Despatch of a communication from the examining division (Time limit: M04) | 10.07.2014 | Reply to a communication from the examining division | 23.12.2014 | Despatch of a communication from the examining division (Time limit: M04) | 16.04.2015 | Reply to a communication from the examining division | 08.06.2016 | Cancellation of oral proceeding that was planned for 13.07.2016 | 27.06.2016 | Despatch of communication that the application is refused, reason: substantive examination [2016/46] | 07.07.2016 | Application refused, date of legal effect [2016/46] | 13.07.2016 | Date of oral proceedings (cancelled) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.04.2014 | Fees paid | Renewal fee | 21.10.2011 | Renewal fee patent year 03 | 23.10.2012 | Renewal fee patent year 04 | 24.10.2013 | Renewal fee patent year 05 | 28.10.2014 | Renewal fee patent year 06 | 22.10.2015 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US2003157135 (TSUJI MORIYA [US], et al) [X] 1-15 * paragraph [0123]; claim 1 *; | [X]WO2007007946 (SEOUL NAT UNIV IND FOUNDATION [KR], et al) [X] 1-15 * page 17, line 10 - line 24; claim 1 *; | [Y]WO2007050668 (LUDWIG INST CANCER RES [US], et al) [Y] 1-15 * the whole document *; | [X]WO2007126163 (SEOUL NAT UNIV IND FOUNDATION [KR], et al) [X] 1-15 * page 24, line 2 - line 6; claims 1-5 *; | [Y]WO2008082156 (SEOUL NAT UNIV IND FOUNDATION [KR], et al) [Y] 1-15 * claim 10 *; | [X] - KAMIJUKU H ET AL, "Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses", MUCOSAL IMMUNOLOGY, (200805), vol. 1, no. 3, ISSN 1933-0219(print) 1935-3456(ele, pages 208 - 218, XP002558333 [X] 1-15 * the whole document * DOI: http://dx.doi.org/10.1038/mi.2008.2 | [Y] - LIU Y ET AL, "A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 312, no. 1-2, ISSN 0022-1759, (20060530), pages 34 - 39, (20060530), XP025158168 [Y] 8 * figure 1 * DOI: http://dx.doi.org/10.1016/j.jim.2006.02.009 | [PX] - KOPECKY-BROMBERG S A ET AL, "Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 27, no. 28, ISSN 0264-410X, (20090608), pages 3766 - 3774, (20090423), XP026134053 [PX] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.vaccine.2009.03.090 |